TY - JOUR
T1 - Effectiveness of almagate in gastroesophageal reflux disease:
T2 - a post-hoc analysis of a randomized cross-over double-blind study
AU - Mearin, Fermin
AU - Pajuelo Lorenzo, Francesca
AU - Rios, Jose
PY - 2021
Y1 - 2021
N2 - Almagate (aluminium-magnesium hydroxycarbonate hydrate) is a widely used antacid in Spain as an over-the-counter formulation. However, data on the control of acidity in patients with gastroesophageal reflux disease (GERD) are scarce. Herein we report a post-hoc analysis of a randomized crossover double-blind trial (ALR-006; data on file), in which equivalent single oral doses (1.5 g) of two formulations of almagate (AlmaxRetard® and Almax®, Laboratorios Almirall, Barcelona, Spain) were both effective for reflux esophagitis.
AB - Almagate (aluminium-magnesium hydroxycarbonate hydrate) is a widely used antacid in Spain as an over-the-counter formulation. However, data on the control of acidity in patients with gastroesophageal reflux disease (GERD) are scarce. Herein we report a post-hoc analysis of a randomized crossover double-blind trial (ALR-006; data on file), in which equivalent single oral doses (1.5 g) of two formulations of almagate (AlmaxRetard® and Almax®, Laboratorios Almirall, Barcelona, Spain) were both effective for reflux esophagitis.
KW - Almagate
KW - Antacids
KW - Cross-over randomized trial
KW - Esophageal pH-metry
KW - Gastric pH-metry
KW - Gastroesophageal reflux disease
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uab_pure&SrcAuth=WosAPI&KeyUT=WOS:000659134400030&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.17235/reed.2020.7449/2020
DO - 10.17235/reed.2020.7449/2020
M3 - Article
C2 - 33267591
SN - 1130-0108
VL - 113
SP - 479
EP - 479
JO - Revista Española de Enfermedades Digestivas
JF - Revista Española de Enfermedades Digestivas
IS - 6
ER -